Edwards Lifesciences
407 hedge funds and large institutions have $6.52B invested in Edwards Lifesciences in 2013 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 111 increasing their positions, 174 reducing their positions, and 67 closing their positions.
Holders
407
Holders Change
-2
Holders Change %
-0.49%
% of All Funds
11.82%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
66
Increased
111
Reduced
174
Closed
67
Calls
$81.4M
Puts
$88.8M
Net Calls
-$7.36M
Net Calls Change
-$75.9M
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$20.5M |
| 2 |
2
BAMCO Inc
New York
|
$101M |
| 3 |
3
Capital World Investors
Los Angeles,
California
|
$877M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$49.1M |
| 5 |
5
D.E. Shaw & Co
New York
|
$4.15M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
476
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
477
Capital Fund Management (CFM)
Paris,
France
| – | – | – | – |
|
|
GTC
478
Ghost Tree Capital
New York
| – | – | – | – |
|
|
ST
479
SpiderRock Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ACH
480
ArrowMark Colorado Holdings
Denver,
Colorado
| – | – | – | – |
|
|
OL
481
Orbitronix LP
Newport Beach,
California
| – | – | – | – |
|
482
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
DM
483
Deerfield Management
New York
| – | – | – | – |
|